PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34657540-8	2021	RESULTS: The diabetic group demonstrated oxidative stress, increased levels of AGEs, decreased renal function, fibrosis in the renal tissue, higher expression of the receptor for advanced glycation end products (RAGE), which were ameliorated in the SM treated group.	swertiamarin	249-251	advanced glycosylation end product-specific receptor	Rattus norvegicus	166-210	
34657540-8	2021	RESULTS: The diabetic group demonstrated oxidative stress, increased levels of AGEs, decreased renal function, fibrosis in the renal tissue, higher expression of the receptor for advanced glycation end products (RAGE), which were ameliorated in the SM treated group.	swertiamarin	249-251	advanced glycosylation end product-specific receptor	Rattus norvegicus	212-216	
34657540-9	2021	In-silico analysis suggests that SM can prevent the binding of AGEs with RAGE.	swertiamarin	33-35	advanced glycosylation end product-specific receptor	Rattus norvegicus	73-77	
34657540-10	2021	CONCLUSIONS: SM ameliorated DN by inhibiting the oxidative stress induced by AGEs.HighlightsSM reduces the levels of hyperglycaemia-induced advanced glycation end products in serum and renal tissue.SM prevents renal fibrosis by inhibiting the EMT in the kidney tissue.The in-silico analysis proves that SM can inhibit the binding of various AGEs with RAGE, thereby inhibiting the AGE-RAGE axis.	swertiamarin	13-15	advanced glycosylation end product-specific receptor	Rattus norvegicus	351-355	
34657540-10	2021	CONCLUSIONS: SM ameliorated DN by inhibiting the oxidative stress induced by AGEs.HighlightsSM reduces the levels of hyperglycaemia-induced advanced glycation end products in serum and renal tissue.SM prevents renal fibrosis by inhibiting the EMT in the kidney tissue.The in-silico analysis proves that SM can inhibit the binding of various AGEs with RAGE, thereby inhibiting the AGE-RAGE axis.	swertiamarin	13-15	advanced glycosylation end product-specific receptor	Rattus norvegicus	384-388	
34657540-10	2021	CONCLUSIONS: SM ameliorated DN by inhibiting the oxidative stress induced by AGEs.HighlightsSM reduces the levels of hyperglycaemia-induced advanced glycation end products in serum and renal tissue.SM prevents renal fibrosis by inhibiting the EMT in the kidney tissue.The in-silico analysis proves that SM can inhibit the binding of various AGEs with RAGE, thereby inhibiting the AGE-RAGE axis.	swertiamarin	198-200	advanced glycosylation end product-specific receptor	Rattus norvegicus	351-355	
34657540-10	2021	CONCLUSIONS: SM ameliorated DN by inhibiting the oxidative stress induced by AGEs.HighlightsSM reduces the levels of hyperglycaemia-induced advanced glycation end products in serum and renal tissue.SM prevents renal fibrosis by inhibiting the EMT in the kidney tissue.The in-silico analysis proves that SM can inhibit the binding of various AGEs with RAGE, thereby inhibiting the AGE-RAGE axis.	swertiamarin	198-200	advanced glycosylation end product-specific receptor	Rattus norvegicus	384-388